BMP9 promotes bone differentiation of bone marrow mesenchymal stem cells via Orai1 pathway

Abstract

Abstract: Objective To explore the role of calcium release activated calcium channel protein 1 (Orai1) in bone marrow mesenchymal stem cells (BMSCs) osteogenesis induced by bone morphogenetic protein 9 (BMP9). Methods BMSCs were isolated by adherent method, and the third generation BMSCs were treated with 10^－5mol/L of BMP9, and the mRNA expression of Orai1 was measured at different time points. RT-qPCR and Western blot were used to value the transfection efficiency after Orai1 knockdown. The osteogenic markers of Runx2, OPN and OCN were detected by RT-qPCR. Hydroxyapatite/PLA/chitosan, a scaffold material for bone tissue engineering, was implanted into the subcutaneous of nude mice. After 4 weeks, the osteogenic effect was examined by microscopy. Results The mRNA expression of Orai1 increased gradually at the 5th day after BMP9 induction (P＜0.05). The gene and protein expression of Orai1 decreased significantly after Orai1 knockdown (P＜0.05). Besides, the osteogenic effect of Orai1 knockdown decreased significantly, and the expression of Runx2, OPN and OCN gene decreased significantly (P＜0.05). Moreover, BMP9 could significantly improve the ectopic osteogenic ability of BMSCs, and Orai1 knockdown significantly inhibited this effect (P＜0.05). Conclusions BMP9 plays an important role in osteogenic differentiation of BMSCs potentially by regulating Orai1.

Key words: bone morphogenetic protein 9 (BMP9), Orai1, bone marrow mesenchymal stem cells (BMSCs), osteogenic differentiation

CLC Number:

ZHOU Jia-wang, LU Guo-hai, LI Xiao-lin. BMP9 promotes bone differentiation of bone marrow mesenchymal stem cells via Orai1 pathway[J]. Basic & Clinical Medicine, 2021, 41(10): 1470-1475.

References

[1]Zheng WW,Chen Q, Zhang Y, et al. BMP9 promotes osteogenic differentiation of SMSCs by activating the JNK/Smad2/3 signaling pathway[J]. J Cell Biochem, 2020, 121: 2851-2863.
[2]Joji K, Changhuan S, Toshiaki W, et al. BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction[J]. Intern J Biochem Cell Biol, 2019, 116: 105614.doi:10.1016/j.biocel.2019.105614.
[3]Ryan EY, Scott ME, Zhang XX, et al. The native ORAI channel trio underlies the diversity of Ca signaling events[J]. Nat Commun, 2020, 11: 2444.doi10.1038/s41467-020-16232-6.
[4]Aidam EG, Noelia EB, Irene SL, et al. RAC1-Dependent ORAI1 Translocation to the leading edge supports lamellipodia formation and directional persistence[J]. Sci Reports 2020, 10: 6580.doi:10.1038/s41598-020-63353-5.
[5]Robinson LJ, Mancarella S, Songsawad D, et al, Gene disruption of the calcium channel Orai1 results in inhibition of osteoclast and osteoblast differentiation and impairs skeletal development[J]. Lab Invest, 2012, 92: 1071-1083.
[6]Hwang SY, Foley J, Numaga-Tomita T, et al. Deletion of Orai1 alters expression of multiple genes during osteoclast and osteoblast maturation[J]. Cell Calcium, 2012, 52: 488-500.
[7]Sami M, Mikhail P, Elam C, et al. The wonders of BMP9: From mesenchymal stem cell differentiation, angiogenesis, neurogenesis, tumorigenesis, and metabolism to regenerative medicine[J]. Genes Dis, 2019, 6: 201-223.
[8]Tiffany JM, Sara MP, Rebecca MB, et al. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice[J]. PLoS One, 2014, 9: e94287.doi:10.1371/journal.pone.0094287.
[9]Rebecca MB, Timothy AN, Tank FH, et al. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease[J]. Proc Nati Acad Sci U S A, 2013, 110: 19567-19572.
[10]Petra P, Tamara M, Arpad V, et al. Intracellular Ca signalling in the pathogenesis of acute pancreatitis: recent advances and translational perspectives[J]. Int J Mol Sci, 2020, 21:4005.doi:10.3390/ijms21114005.
[11]Barradas AMC, Fernandes HAM, Groen N, et al. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells[J]. Biomaterials, 2012, 33: 3205-3215.
[12]Driel MV, Koedam M, Buurman CJ, et al. Evidence that both 1α,25-dihydroxyvitamin D₃ and 24-hydroxylated D₃ enhance human osteoblast differentiation and mineraliza-tion[J]. J Cell Biochem, 2006, 99: 922-935.
[13]Miyahara T, Simoura T, Osahune N, et al. A highly potent 26,27-hexafluoro-1a,25-dihydroxyvitamin D₃ on calcification in SV40-transformed human fetal osteoblastic cells[J]. Calcif Tissue Int, 2002, 70: 488-495.
[14]Ren J, Wu JH. 17β-estradiol rapidly activates calcium release from intracellular stores via the GPR30 pathway and MAPK phosphorylation in osteocyte-like MLO-Y4 cell[J]. Calcif Tissue Int, 2012, 90: p.411-419.
[15]Angela R, Mariane P, Ariane Z, et al. 1α,25(OH)₂-Vitamin D₃ stimulates rapid plasma membrane calcium influx via MAPK activation in immature rat Sertoli cells[J]. Biochimie, 2012, 94: 146-154.